ABILIFY MAINTENA is a once-monthly* injection given by a healthcare provider for the treatment of schizophrenia in adults and the maintenance treatment of bipolar I disorder in adults. It's gradually released in the body all month long, and was proven to provide long-lasting symptom control.
*You should continue to take your current oral antipsychotic medication for 2 weeks after your first treatment with ABILIFY MAINTENA. Before starting treatment with ABILIFY MAINTENA, it's important to talk with your healthcare provider about past medications you've been prescribed, mood episodes or relapses you've experienced in the past year, and any side effects you may have had with your current medication. Have you already taken the pill form of aripiprazole?
• If you have taken the pill form, be sure to tell your healthcare provider. This information will help them figure out how much medicine your body will be able to tolerate when you start ABILIFY MAINTENA
• If you haven't taken the pill form, tell your healthcare provider. You will be asked to take the pill form for 2 weeks before getting your first injection of ABILIFY MAINTENA, so your healthcare provider can see how well your body tolerates the medicine
INDICATIONS and IMPORTANT SAFETY INFORMATION for ABILIFY MAINTENA® (aripiprazole)
INDICATIONS:
ABILIFY MAINTENA is a prescription medicine given by injection by a healthcare professional:
• for the treatment of schizophrenia in adults
• alone as maintenance treatment of bipolar I disorder in adults
It is not known if ABILIFY MAINTENA is safe and effective in children under 18 years of age. ABILIFY MAINTENA increases the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). ABILIFY MAINTENA is not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY MAINTENA. ABILIFY MAINTENA may cause serious side effects, including:
• Increased risk of stroke and ministroke has been reported in clinical studies with oral aripiprazole of elderly people with dementia-related psychosis and can lead to death.
• Neuroleptic malignant syndrome (NMS), a serious condition that can lead to death. Call your healthcare provider or go to the nearest emergency room right away if you have some or all of the following symptoms of NMS: high fever, stiff muscles, confusion, sweating, or changes in pulse, heart rate, and blood pressure.
• Uncontrolled body movements (tardive dyskinesia). ABILIFY MAINTENA may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop receiving ABILIFY MAINTENA. Tardive dyskinesia may also start after you stop receiving ABILIFY MAINTENA.
• Problems with your metabolism such as:
- High blood sugar (hyperglycemia) and diabetes: Increases in blood sugar can happen in some people who receive ABILIFY MAINTENA. Extremely high blood sugar can lead to coma or death. If you have diabetes or risk factors for diabetes, such as being overweight or a family history of diabetes, your healthcare provider should check your blood sugar before you start receiving ABILIFY MAINTENA and during your treatment. Call your healthcare provider if you have any of these symptoms of high blood sugar while receiving ABILIFY MAINTENA:
-- feel very thirsty
-- need to urinate more than usual
-- feel very hungry
-- feel weak or tired
-- feel sick to your stomach
-- feel confused, or your breath smells fruity
- Increased fat levels (cholesterol and triglycerides) in your blood.
- Weight gain. You and your healthcare provider should check your weight regularly during treatment.
• Unusual and uncontrollable (compulsive) urges. Some people receiving ABILIFY MAINTENA have had unusual strong urges to gamble and gambling that cannot be controlled (compulsive gambling). Other compulsive urges include sexual urges, shopping, and eating or binge eating. If you or your family members notice that you are having unusual urges or behaviors, talk to your healthcare provider.
• Decreased blood pressure (orthostatic hypotension). You may feel lightheaded or faint when you rise too quickly from a sitting or lying position.
• Falls. ABILIFY MAINTENA may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills, which may lead to falls that can cause fractures or other injuries.
• Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment.
• Seizures (convulsions)
• Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Do not drive a car, operate machinery, or do other dangerous activities until you know how ABILIFY MAINTENA affects you. ABILIFY MAINTENA may make you feel drowsy and affect your judgement, thinking, or motor skills.
• Problems controlling your body temperature so that you feel too warm. Do not become too hot or dehydrated while you receive ABILIFY MAINTENA. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Do not wear too much clothing or heavy clothing. Drink plenty of water.
• Difficulty swallowing that can cause food or liquid to get into your lungs. Do not drink alcohol while you receive ABILIFY MAINTENA. Before receiving ABILIFY MAINTENA, tell your healthcare provider about all of your medical conditions, including if you:
• have never taken aripiprazole before
• have or had diabetes or high blood sugar or a family history of diabetes or high blood sugar
• have or had high levels of total cholesterol, LDL cholesterol, or triglycerides, or low levels of HDL cholesterol
• have or had low or high blood pressure
• have or had heart problems or a stroke
• have or had a low white blood cell count
• have or had seizures (convulsions)
• have problems that may affect you receiving an injection in your arm or buttocks
• are pregnant or plan to become pregnant. ABILIFY MAINTENA may harm your unborn baby. If you become pregnant during treatment with ABILIFY MAINTENA, talk to your healthcare provider about the risk to your unborn baby and about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/
• are breastfeeding or plan to breastfeed. ABILIFY MAINTENA can pass into your milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive ABILIFY MAINTENA. Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. ABILIFY MAINTENA and other medicines may affect each other causing possible serious side effects. Do not start or stop any medicines during treatment with ABILIFY MAINTENA without talking to your healthcare provider first. The most common side effects of ABILIFY MAINTENA include: weight gain, restlessness or feeling like you need to move (akathisia), injection site pain, or sleepiness (sedation). It is important to contact your healthcare provider if you experience prolonged, abnormal muscle spasms or contractions, which may be signs of a condition called dystonia. These are not all the possible side effects of ABILIFY MAINTENA. If you have any questions about your health or medicines, talk to your healthcare provider. You are encouraged to report side effects of ABILIFY MAINTENA. Please contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch). Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, at AbilifyMaintenaPI.com, and MEDICATION GUIDE at AbilifyMaintenaMedGuide.com.
©2025 Otsuka America Pharmaceutical, Inc. Trademarks used are property of their respective owners. August 2025 09US25EBC0037
